Publication Ethics and Malpractice Statement in the Journal of Renal Injury Prevention

Publication and authorship

1.    All submitted manuscripts to the Journal of Renal Injury Prevention are subject to strict peer-review process by at least two international reviewers and one local reviewer that are experts in the area nephrology and nephropathology.
 
2.    The factors that are taken into account in review are relevance, soundness, significance, originality, readability and language.
 
3.    The possible decisions include acceptance, acceptance with revisions, or rejection.
 
4.    If authors are encouraged to revise and resubmit a submission, there is no guarantee that the revised submission will be accepted.
 
5.    Rejected manuscripts will not be re-reviewed.
 
6.    The manuscript acceptance is constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism.
 
7.    No research can be included in more than one publication.
 

Authors' responsibilities
1.    Authors must certify that their manuscripts are their original work.
 
2.    Authors must certify that the manuscript has not previously been published elsewhere.
 
3.    Authors must certify that the manuscript is not currently being considered for publication elsewhere.
 
4.    Authors must participate in the peer review process.
 
5.    Authors are obliged to provide retractions or corrections of mistakes.
 
6.    All Authors mentioned in the paper must have significantly contributed to the research.
 
7.    Authors must state that all data in the paper are real and authentic.
 
8.    Authors must notify the editors of any conflicts of interest.
 
9.    Authors must identify all sources used in the creation of their manuscript.
 
10.    Authors must report any errors they discover in their published paper to the editors.

 Please complete authors’ agreement form provided on the journal website and send    through email to the journal

Reviewers' responsibilities
1.    Reviewers should keep all information regarding papers confidential and treat them as privileged information.
 
2.    Reviews should be conducted objectively, with no personal criticism of the author
 
3.    Reviewers should express their views clearly with supporting arguments
 
4.    Reviewers should identify relevant published work that has not been cited by the authors.
 
5.    Reviewers should also call to the editor- in-chief's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
 
6.    Reviewers should not review manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

For more information please look at the checklist for review provided on the journal website.
 
Editors' responsibilities
1.    Editors have complete responsibility and authority to reject/accept an article.
 
2.    Editors are responsible for the contents and overall quality of the publication.
 
3.    Editors should always consider the needs of the authors and the readers when attempting to improve the publication.
 
4.    Editors should guarantee the quality of the papers and the integrity of the academic record.
 
5.    Editors should publish errata pages or make corrections when needed.
 
6.    Editors should have a clear picture of a research's funding sources.
 
7.    Editors should base their decisions solely one the papers' importance, originality, clarity and relevance to publication's scope.
 
8.    Editors should not reverse their decisions nor overturn the ones of previous editors without serious reason.
 
9.    Editors should preserve the anonymity of reviewers.
 
10.    Editors should ensure that all research material they publish conforms to internationally accept ethical guidelines.
 
11.    Editors should only accept a paper when reasonably certain.
 
12.    Editors should act if they suspect misconduct, whether a paper is published or unpublished, and make all reasonable attempts to persist in obtaining a resolution to the problem.
 
13.    Editors should not reject papers based on suspicions, they should have proof of misconduct.
 
14.    Editors should not allow any conflicts of interest between staff, authors, reviewers and board members.

Search to Nickan website

Site Traffic

Today4
Yesterday47
This week183
This month1521
Total119865

Thursday, 29 June 2017 02:05

The theme of World Hypertension Day 2014: Know your Blood Pressure

Firstly World Hypertension Day inaugurated in May 2005 and has become an annual event ever since. The aim of the World Hypertension Day is to promote public alertness of high blood pressure and to promote citizens of all countries to prevent and control this silent killer, the modern epidemic.World Hypertension Day was initiated firstly by the World Hypertension League.High blood pressure (hypertension) is considered as the silent killer since it has no apparent symptoms. Investigations show that the disease involves more than 1.5 billion people global, and around seven million people die every year from hypertension. 

Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD)

The definition of CKD-MBD is different than the previously recognized as "renal osteodystrophy", and it refers to a systemic disorder of mineral and bone metabolism due to CKD manifested by either one or a combination of the following:
•Abnormalities of calcium, phosphorus, parathyroid hormone (PTH), or vitamin D metabolism.
•Abnormalities in bone turnover, mineralization, volume, linear growth, or strenght.
•Vascular or other soft-tissue calcification.
The term "renal osteodystrophy" is now limited to an alteration of bone morphology in patients with CKD, and it is one measure of the skeletal component of the systemic disorder of CKD-MBD that is quantifiable by histomorphometry of bone biopsy.

 

World Kidney Day 2014:chronic kidney disease and aging

World Kidney Day (WKD) is a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF).Seven years on from the first campaign, World Kidney Day (WKD) has turned into a global phenomenon. On March 13, 2014, medical professionals, government officials, the general public, celebrities and patients will take action locally.
Implication for health policy/practice/research/medical education
In 2014 World Kidney Day (WKD) will focus on chronic kidney disease and aging.The mission of WKD is to raise awareness so that everyone cares for their kidneys and, if appropriate, check to assess if they are at risk for kidney disease. Prevention of kidney disease, early detection, and subsequent kidney protection are critical aims for World Kidney Day.
Our research group is working on the below projects
1-Oxford classification in Iranian IgA nephropathy patients [Renal pathology unite of Dr. Baradaranlaboratory, Isfahan, Iran].
2- Significance of C4d deposits in IgA nephropathy [Renal pathology unite of Dr. Baradaran laboratory, Isfahan, Iran].
3-Renal tubular cell protection by herbal anti-oxidants [Medical Plants Research Center; Shahrekord University of Medical Sciences, Shahrekord, Iran]
4-R229Q Polymorphism of NPHS2 Gene in Patients with Late-Onset Steroid-Resistance Nephrotic Syndrome [Chronic Kidney Disease Research Center; Tabriz University of Medical Sciences,Tabriz, Iran]

Recently Published Papers
Baradaran A. Antiphospholipid syndrome-associated nephropathy; a nephropathy needs classification. J Nephropharmacol. 2012; 1(1):7-9.
Implication for health policy/practice/research/medical education
A suggested classification for antiphospholipid syndrome-associated nephropathy, should be simple and practical. However, the suggestion of a new classification for antiphospholipid syndrome-associated nephropathy will involve a magnificent amount of work and will necessitate a working group, hence, more studies on this topic is suggested.

Nasri H. Antiphospholipid syndrome-associated nephropathy: Current concepts . J Ren Inj Prev 2013; 2(1): 1-2.
Implication for health policy/practice/research/medical education
Renal pathologists and nephrologists should be aware of the morphologic characteristics of APS-nephropathy when they reviewbiopsies of lupus nephropathy patients, especially those with positive antiphospholipid antibodies.

Mubarak M, Nasri H.What nephrolopathologists needto know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions? J Nephropathology. 2014; 3(1): 4-8.
Implication for health policy/practice/research/medical education
There is sufficient epidemiological, clinical and histopathological evidence to show that antiphospholipid syndrome-associated nephropathy is a distinctive lesion caused by antiphospholipid antibodies in patients with different forms of antiphospholipid syndrome. It is now time to devise a classification for an accurate diagnosis and prognostication of the disease.